Wade Berrettini is a Psychiatry physician affiliated with University of Pennsylvania. OpenAlex indexes 299 publications with 21,338 citations (h-index 64); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3535 Market St Fl 3
Philadelphia, PA 191043317
Telephone
215-746-6700Registry record last updated 12 Sept 2018.
Clinical trials
- Trial Of NS2359 For The Treatment of Cocaine Dependence
Sponsor: University of Pennsylvania
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20235 payments
- Merck Sharp & Dohme LLCProgram year20225 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
19 NIH research awards on record, funded 1995–2021 per NIH RePORTER. The latest:
- Clinical and Genetic Study of Prescription Opioid Addiction
Geisinger Clinic
FY2021$737,349R01DA044015 - Clinical and Genetic Study of Prescription Opioid Addiction
Geisinger Clinic
FY2020$792,666R01DA044015
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition
Proceedings of the National Academy of Sciences
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
Nabila Dahodwala, MD
University of Pennsylvania
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”